Aspen Healthcare enters into partnership with Nova Healthcare, the specialist private patient cancer facility of the Leeds Cancer Centre
Aspen Healthcare, which owns and operates more than 250 private healthcare beds across the UK, including a cancer centre in London, has acquired fifty percent of the ownership of Nova Healthcare.
Nova Healthcare, specializes in the care and treatment for patients that have been diagnosed with cancer, blood disorders and neurological diseases. The facility is a successful example of an independent sector healthcare provider working in co-operation with prominent local NHS consultants and the Leeds Teaching Hospitals NHS Trust to provide private patient services.
Services are provided at the Leeds Cancer Centre at St James’s University Hospital, which is one of the largest and most technologically advanced cancer diagnosis and treatment centres in Europe. Ron Gilden, founder and Director of Nova Healthcare said: “We are proud and excited to welcome Aspen Healthcare as our partner at Nova Healthcare; their experience of running high quality surgical and inpatient facilities will be instrumental to our expansion plans to develop new services in partnership with our consultants and the Trust”.
Commenting on the transaction, Aspen Healthcare’s CEO, Des Shiels, said: “Leeds Cancer Centre is an excellent facility with a proud tradition of delivering quality cancer care to the people of Leeds and the surrounding regions. Aspen Healthcare is very excited about this joint venture and intends to build upon the Trust’s excellent reputation for Cancer Services to grow and develop private patient services at Nova Healthcare. This partnership presents a unique opportunity to support the NHS Trust whilst at the same time supporting clinicians in their private practice in order to deliver excellent and advanced clinical care”.
About Aspen Healthcare
Aspen Healthcare owns and operates eight healthcare facilities in the UK, and as a provider has extensive knowledge of the UK healthcare market. The company’s core business is the management and operation of private hospital and other medical facilities, many as a joint venture partnership with Consultants. Aspen Healthcare’s current facilities are:
· Parkside Hospital, Wimbledon, SW London;
· Cancer Centre London, Wimbledon, SW London;
· Holly House Hospital, Buckhurst Hill, NE London;
· Highgate Hospital, Highgate, NW London;
· The Edinburgh Clinic, Edinburgh;
· The Claremont Hospital, Sheffield;
· Midland Eye, Solihull; and
· The Chelmsford, Chelmsford, Essex.
About Nova Healthcare and Healthcare Technologies International (HTI)
Nova Healthcare was formerly a wholly owned subsidiary of Healthcare Technologies International (HTI). Founded in 1972, HTI has developed over 200 cancer diagnostic and treatment centres. Specifically in the UK, HTI has developed large NHS centres in Belfast and Leeds and private centres in London and Wimbledon. In partnership with Guy’s and St. Thomas’ NHS Foundation Trust, HTI is currently developing a satellite cancer centre at Queen Mary Hospital, Sidcup. Committed to providing state of the art cancer treatment and expanding access to the latest technologies, HTI, through its subsidiary Proton International, is currently developing proton treatment centres in Europe, the U.S. and Latin America. Healthcare Technologies International works in partnership with NHS Trusts to expand and integrate private patient oncology services.